Table 6. Lipid parameters expressed in mM in the normal total cholesterol group (TC <5mM) between baseline and 12 weeks intervention study in the active (Lactobacillus plantarum ECGC 13110402) and placebo treatment groups.
| Outcome | Group | N | Baseline Mean (SD) |
12 weeks Mean (SD) |
Change Mean (SD) [range] |
% Change Mean (SD) [range] |
Group Difference Mean (95% CI) |
P-value |
|---|---|---|---|---|---|---|---|---|
| TC | Placebo | 11 | 4.50 (0.28) | 4.79 (0.43) | 0.29 (0.60) [-0.7, 1.4] | 7.1 (13.7) [-14.6, 34.1] | 0 | |
| Active | 12 | 4.53 (0.33) | 4.61 (0.42) | 0.08 (0.38) [-0.5, 1.0] | 2.0 (8.5) [-10.9, 23.3] | -0.19 (-0.56, 0.19) | 0.31 | |
| HDL-C | Placebo | 11 | 1.09 (0.28) | 1.11 (0.23) | 0.02 (0.19) [-0.2, 0.5] | 4.5 (22.3) [-14.3, 62.5] | 0 | |
| Active | 12 | 1.34 (0.30) | 1.44 (0.42) | 0.10 (0.19) [-0.1, 0.5] | 6.2 (12.9) [-12.5, 33.3] | 0.09 (-0.10, 0.27) | 0.33 | |
| LDL-C | Placebo | 11 | 2.88 (0.33) | 3.15 (0.47) | 0.26 (0.59) [-0.8, 1.3] | 10.5 (21.0) [-22.9, 52.0] | 0 | |
| Active | 12 | 2.71 (0.31) | 2.72 (0.28) | 0.02 (0.30) [-0.6, 0.6] | 1.3 (11.7) [-21.4, 26.1] | -0.39 (-0.74, -0.04) | 0.03 | |
| TAG | Placebo | 11 | 1.14 (0.51) | 1.15 (0.38) | 0.02 (0.41) [-0.9, 0.5] | 12.3 (37.3) [-52.9, 62.5] | 0 | |
| Active | 12 | 1.08 (0.39) | 0.97 (0.35) | -0.12 (0.25) [-0.5, 0.2] | -8.1 (25.4) [-55.6, 28.6] | -0.01 (-0.22, 0.23) | 0.96 |
TC: total cholesterol; HDL: High-density lipoprotein cholesterol; LDL: low-density lipoprotein cholesterol; TAG: triacylglycerol; N: number of participants